Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
July 06 2006 - 12:00PM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., July 6 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Daniel N. Swisher, Jr., Chief Executive Officer and President, will
present a company update at the C. E. Unterberg, Towbin Emerging
Growth Conference on Tuesday, July 11, 2006 at 9:06 a.m. at the
Mandarin Oriental Hotel in New York, NY. Interested parties may
access a webcast of the presentation by visiting the Sunesis
website at http://ir.sunesis.com/. A replay of the webcast will be
archived on the "Calendar of Events" page in the Investors and
Media section of the Sunesis website for two weeks until July 25,
2006. About Sunesis Pharmaceuticals Sunesis is a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small molecule therapeutics for oncology
and other serious diseases. Sunesis has built a broad product
candidate portfolio through internal discovery and in-licensing of
novel cancer therapeutics. Sunesis is advancing its product
candidates through in-house research and development efforts and
strategic collaborations with leading pharmaceutical and
biopharmaceutical companies. For further information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com/.
Forward-Looking Statements This press release may contain
forward-looking statements that involve substantial risks and
uncertainties. Sunesis may not actually achieve the plans,
intentions or expectations contained in such forward-looking
statements. Actual results or events could differ materially from
the plans, intentions and expectations contained in such
forward-looking statements. Sunesis does not assume any obligation
to update any such forward-looking statements. DATASOURCE: Sunesis
Pharmaceuticals, Inc. CONTACT: investors, Eric Bjerkholt, CFO of
Sunesis Pharmaceuticals, Inc., +1-650-266-3717, or media, Karen L.
Bergman or Michelle Corral, both of BCC Partners, +1-650-575-1509,
or +1-415-794-8662, for Sunesis Pharmaceuticals, Inc. Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles